PUBLISHED COMMERCIAL FIELDSValues stay separate.
A tender estimate and an award value answer different questions. Neither is treated as cash paid.
- Award value
- £272,700
award field- Tender value
- £272,700
tender field- Procurement method
- Call-off from a framework agreement
- Category
- services
- CPV
- 85111800
Pathology services- Delivery
- Not stated
TN37 7RD
PUBLISHED DESCRIPTION
What the notice says
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient. Additional information: This is a call off contract from framework 2023/S 000-028831 based on previous contracts usage.
Tender statuscomplete